UBS analyst David E. Strauss reiterates a ‘Buy’ rating on Esterline Technologies Corp.
UBS analyst A.J.
In a research note issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating and boosted his price target on Achillion Pharmaceuticals (ACHN) to …
In a research note issued this morning, H.C.
In a research note released this morning, H.C.
Roth Capital initiated coverage on Fusion IO Inc. (FIO) with a Buy rating and $12.
Analyst Krishna Shankar of Roth Capital upgraded Intel Corporation (INTC) from Neutral to Buy, and boosted his price target on INTC from $28.00 to $35.
Roth Capital reiterated coverage yesterday on Uranium Resources Inc. (URRE) with a Buy rating and $4.
In a report published today, Roth Capital analyst Ed Arce resumed coverage on Conatus Pharmaceuticals Inc. (CNAT) with a Buy rating and $19.